TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis-Reference-Cited by-同舟云学术

TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis

Published:2020-03-04 Issue: Volume: Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Zhang Liping¹,Zhang Bingqian¹,Wei Muyun²,Xu Zhen¹,Kong Weiya¹,Deng Ke¹,Xu Xinxin³,Zhang Lin⁴,Ζhao Xingbo²,Yan Lei¹

Affiliation:

1. School of Medicine, Shandong University, Jinan, Shandong 250012, P.R. China

2. Department of Obstetrics and Gynecology, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

3. Center for Reproductive Medicine, Reproductive Hospital Affiliated to Shandong University, Jinan, Shandong 250021, P.R. China

4. Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Maternal and Child Health Care Hospital of Shandong Province, Shandong University, Jinan, Shandong 250001, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The E3 ligase TRIM22 functions as a tumor suppressor in breast cancer by targeting CCS for proteasomal degradation to inhibit STAT3 signaling;Cancer Letters;2024-09

2. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches;Molecular Cancer;2024-07-25

3. Role and molecular mechanism of NOD2 in chronic non-communicable diseases;Journal of Molecular Medicine;2024-05-14

4. Prognostic value of inflammation and immune-related gene NOD2 in clear cell renal cell carcinoma;Human Cell;2024-03-21

5. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8;mBio;2024-02-14